Skip to main content
SpringerLink
Log in

Die Bakteriologie, Epidemiologie und spezifische Therapie der Pneumokokkeninfektionen des Menschen unter besonderer Berücksichtigung der Pneumonie

  • Chapter
Ergebnisse der Hygiene Bakteriologie Immunitätsforschung und Experimentellen Therapie

Zusammenfassung

Dank der grundlegenden Arbeiten von NEUFELD und HÄNDEL über die Serumtherapie der Pneumonie, die zu der Feststellung führten, daß verschiedene, immunologisch vollkommen voneinander zu trennende Typen der Pneumokokken zu unterscheiden sind, wurden der Forschung über das Pneumonieproblem Anregungen vermittelt, die bis in die Gegenwart hinein außerordentlich wertvolle Fortschritte in unseren Kenntnissen über die Ätiologie, Pathogenese, Epidemiologie und die spezifische Therapie zu erbringen vermochten. Keineswegs ist aber auf diesem Gebiet die Forschungsarbeit abgeschlossen, viele Teilfragen konnten bisher über das Anfangsstadium noch nicht hinausgetragen werden. Es seien nur die Versuche erwähnt, eine Bekämpfung der Pneumonie durch Schutzimpfungsmaßnahmen durchzuführen. Man denke an die fehlenden oder doch nur mangelhaften Maßnahmen einer spezifischen Therapie der Pneumonien des frühen Kindesalters (in dem die verschiedenen Pneumonieformen die häufigste Todesursache darstellen), an die noch nicht ausreichenden Erfolge der Serumtherapie, besonders die der Typen II und III, sowie der Gruppe IV. Selbst grundlegende bakteriologische Fragen über die Variabilität der Pneumokokken, über die Typenverteilung der Pneumokokken bei den meisten menschlichen Infektionen, wie Herdpneumonien, Peritonitis, Bronchitis, Conjunctivitis u. a. harren noch endgültiger Lösung. Es mag vermessen erscheinen, der 1928 aus der so berufenen Feder von NEUFELD zusammen mit SCHNITZER erschienenen Monographie über „Pneumokokken“ nach relativ kurzer Zeit eine zusammenfassende Darstellung über die Pneumoniefrage folgen zu lassen.

Aus dem Hygienischen Institut der Universität Heidelberg.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Adam, A.: Pneumococcus planus. Ein Beitrag zur Ätiologie der grippalen Erkrankungen des Kindesalters. Jb. Kinderheilk. 112, III. F. 62, H. 5/6, 237–250 (1926).

    Google Scholar 

  2. AiDin, R.: The antigen treatment of pneumonia in infancy and childhood. Brit. med. J. 1927, 918.

    Google Scholar 

  3. Alston u. Stewart: Some observations on passive immunity in the normal subject produced by antipneumococcic sera. Brit. J. exper. Path. 12, 49–56 (1931).

    Google Scholar 

  4. Amoss, H. L.: The composite nature of a pure culture of a virulent pneumococcus. J. of exper. Med. 41, 649 (1925).

    CAS  Google Scholar 

  5. Amoss, H. L. Specific soluble substances of the pneumococcus in the blood in pneumonia. Proc. Soc. exper. Biol. a. Med. 28, 23–25 (1930).

    CAS  Google Scholar 

  6. Amzel, R.: Sur la 4 variabilité du pneumocoque. Pneumocoque des pneumonies et des sujets sains. O. r. Soc. Biol. Paris 96, 1489 (1927).

    Google Scholar 

  7. Armstrong, R. R.: A swift and simple method for deciding pneumococcal “type”. Brit. med. J. 3657, 214–215 (1931).

    Google Scholar 

  8. Avery (1), Chickering, Cole and Dochez: Acute lobar pneumonia. Monogr. Rockefeller Inst. med. Res. 1917, Nr 7.

    Google Scholar 

  9. Avery (2): Determination of types of pneumococcus in lobar pneumonia. J. amer. med. Assoc. 70, 17 (1918).

    Google Scholar 

  10. Avery u. Neill, M. James: The antigenic properties of solutions of pneumococcus. J. of exper. Med. 42, 355 (1925).

    Google Scholar 

  11. Avery u. Michael Heidelberger: Immunological relationship of cell constituent of pneumo coccus. n. J. of exper. Med. 42, 367 (1925).

    Google Scholar 

  12. Avery u. W. S. Tjllett: Anaphylaxis with the type-specific carbohydrates of pneumococcus.J. of exper. Med. 49, 251–266 (1929).

    Google Scholar 

  13. Bachmann, W.: Studien zur Erkältungsfrage. HL Arch. f. Hyg. 102, 263–286 (1929).

    Google Scholar 

  14. Baerthlein, Kahl: Die Autovaccinebehandlung der Pneumonie. Arb. Reichsgesdh.amt 57, 681–689 (1926).

    Google Scholar 

  15. Bailey, G. Howard: Accessory etiologic factors of respiratory infektion in rabbits. II. The effect of fatigue on the susceptibility of rabbits to intranasal infection with type I pneumococcus. Amer. J. Hyg. 9, 192–206 (1929).

    Google Scholar 

  16. Baldwin, H. S. u. R. L. Cecil: The rationale of specific therapy in Pneumococcus pneumonia. J. amer. med. Assoc. 87, 1709–1715 (1926).

    Google Scholar 

  17. Banzhaf: The distribution of the immune bodies occurring in types I-, H- and III-anti- pneumococcus serum. Proc. Soc. exper. Biol. a. Med. 22, 359 (1925).

    Google Scholar 

  18. Barach, Alvan L.: Rate of development of pneumococcus immunity. Proc. Soc. exper. Biol. a. Med. 25, 558–560 (1928).

    Google Scholar 

  19. Barach, Alvan L. u. Max Soroka: Factors involved in the production of immunity with pneumococcus vaccine. I. Active and passive immunity during the first seven days after injection of antigen. J. of exper. Med. 48, 83–104 (1928).

    CAS  Google Scholar 

  20. Bauer, John T. u. St. Clair Huston: Pneumococcus types in acute mastoiditis and „primary“ pneumococcus meningitis. Prelim, erport. J. amer, med. Assoc. 90, 1429–1430 (1928).

    Google Scholar 

  21. Benz, H. J.: Pneumonia quarantine. Amer. J. publ. Health 18, 433–438 (1928).

    CAS  Google Scholar 

  22. Berger u. Engelmann (1): Einheit der Pneumokokken und Streptokokken. Dtsch. med. Wschr. 1925, Nr 32.

    Google Scholar 

  23. Berger u. Engelmann (2): Über Änderungen des serologischen Typs bei einem Pneumococcus. Klin. Wschr. 1926, 599–600.

    Google Scholar 

  24. Berger u. Engelmann u. Silberstein: Inulinvergärung in der Streptokokken-, Pneumokokkengruppe. Klin. Wschr. 1926, Nr 49.

    Google Scholar 

  25. Blake u. Cecil: Studies on experimental pneumonia. I.–HI. J. of exper. Med. 31, 403, 445, 499 (1920).

    Google Scholar 

  26. Bonnahon, J.: Contribution à l’étude bactériologique des suppurations auriculaires à microbes pyogènes aérobies. Presse méd. 1930, 1370.

    Google Scholar 

  27. Brand, W. u. R. Kochmann: Die Behandlung der Bronchopneumonie im Säuglings- und Kleinkinderalter mit Pneumokokkenserum. Münch, med. Wschr. 1926, 479.

    Google Scholar 

  28. Van den Branden, F. u. L. Formara: Résultats de la vaccination antipneumococcique appliquée aux indigènes de Léopoldville. Ann. Soc. belge Méd. trop. 6, 219 (1926).

    Google Scholar 

  29. Brundlage, Dean K.: Importance of respiratory diseases as a cause of disabüity among industrial workers. Publ. Health Rep. 1928, 603.

    Google Scholar 

  30. Buchholz, Leo: Über die Beziehungen der Enterokokken zu den Milchsäurestreptokokken und Pneumokokken. Jb. Kinderheilk. 124, 347–356 (1929).

    Google Scholar 

  31. Bull, C. G. u. C. H. McKee (1): The sensitization of rabbits to products of the pneumococcus resulting from an acute infection with this organism. Amer. J. Hyg. 9, 666–681 (1929).

    Google Scholar 

  32. Bull, C. G. u. C. H. McKee (2): Respiratory immunity in rabbits. II. Intranasal infection and immunization with pneumococci. Amer. J. Hyg. 7, 627–634 (1927).

    Google Scholar 

  33. Bull, C. G. u. C. H. McKee (3): Respiratory immunity in rabbits. VI. The effects of immunity on the carrier state of the pneumococcus and Bacillus bronchisepticus. Amer. J. Hyg. 8, 723–729 (1928).

    Google Scholar 

  34. Bull, C. G. u. C. H. McKee (4): Respiratory immunity in rabbits. VU. Resistance to intranasal infection in the absence of demonstrable antibodies. Amer. J. Hyg. 9, 490–499 (1929).

    Google Scholar 

  35. Bull, C. G. u. G.H.Mc Kee (5): Respiratory immunity in rabbits. viii. Rabbits immunized with pneumococcus types II, III and IV resist intranasal infection with type I. Amer. J.Hyg. 10, 229–235 (1929).

    Google Scholar 

  36. Bull, C. G. u. C. H. McKee u. Shau Ming Tao: A method for determining the antipneumococcal properties of whole blood and the productive power of immune serum. Amer. J. Hyg. 7, 648–661 (1927).

    Google Scholar 

  37. Bullowa, Jesse G. M. (1): Use of antipneumococcic refined serum in lobar pneumonia. J. amer. med. Assoc. 90, 1354–1358 (1928).

    Google Scholar 

  38. Bullowa, Jesse G. M. (2): The serum treatment and its evalution in lobar pneumonia. Bull. N.Y. Acad. Med. 5, 328–362 (1929).

    PubMed  CAS  Google Scholar 

  39. Bullowa, Jesse G. M. (3): Serum treatment of the Pneumococcus pneumonias. Brit. med. J. 1, 943–946.

    Google Scholar 

  40. Bürgers: Studien zum Erkältungsproblem. Schriften der Königsberger gelehrten Gesellschaft. Halle a/S. 1929.

    Google Scholar 

  41. Bürgers u. Herz: Über das Vorkommen der verschiedenen Pneumokokkentypen. Zbl. Bakter. Orig. 91, 42 (1923/24).

    Google Scholar 

  42. Burgess, Alexander M.: Sudden death following the administration of concentrated pneumococcus serum. J. amer. med. Assoc. 98, 768 (1929).

    Google Scholar 

  43. Burhans u. Gerstenberger: The protective power of infants and maternal serum against pneumocoeci. Amer. J. Dis. Childr. 28, 415 (1924).

    Google Scholar 

  44. Castellanos, A.: Die Pneumokokkenseptieämien des Bondes. Bol. Soc. cub. Pediatr. 2, 331–366 (1930).

    Google Scholar 

  45. Cecil (1): Immunisation against pneumonia. Medicine 4, 395 (1925).

    Google Scholar 

  46. Cecil (2): The specific treatment of lobar pneumonia. Arch. int. Med. 41, 295 (1930).

    Google Scholar 

  47. Cecil u. Austin: Results of prophylactic inoculation against pneumococcus in 12519 men. J. of exper. Med. 28, 19 (1918).

    Google Scholar 

  48. Cecil u. Baldwin: The treatment of lobar pneumonia with subcutaneous infection of pneumo coccus antibody solution. J. of Pharmacol. 24, 1 (1924).

    Google Scholar 

  49. Cecil u. Blake: Studies in experimental pneumonia. IV, V, VI und VII. J. of exper. Med. 31, 519, 657, 685; 82, 1 (1920).

    Google Scholar 

  50. Cecil u. Larsen: Clinical and bacteriological study of 1000 cases of lobar pneumonia etc. J. amer. med. Assoc. 79, 343 (1922).

    Google Scholar 

  51. Cecil u. N. Plummer: Pneumococcus Type I Pneumonia. J. amer. med. Assoc. 95,1547–1553.

    Google Scholar 

  52. Cecil u. Steffen: Studies in pneumococcus immunity. I. J. of exper. Med. 34, 245 (1921); II. J. of exper. Med. 38, 149 (1923); IV. Bull. Hyg. Labor. Washington 141, 1 (1925); V. Bull. Hyg. Labor. Washington 141, 19 (1925).

    Google Scholar 

  53. Cecil u. Vaughan: Results of prophylactic vaccination against pneumonia at camp Wheeler. J. of exper. Med. 29, 457 (1919).

    Google Scholar 

  54. Cecil H. S. Baldwin u. N. P. Larsen: Clinical and bactériologie study of two thousand tyed cases of lobar pneumonia. I: Arch. int. Med. 40, 253–280 (1927). H: Trans. Assoc. amer. Physicians 41, 208–223 (1926).

    Google Scholar 

  55. Cecil u. Sutliff: The treatment of lobar pneumonia with concentrated antipneumococcus serum. J. amer. med. Assoc. 91, 2035–2042 (1928).

    Google Scholar 

  56. Chaillons, J. u. L. Cotoni: Étude expérimentale du traitement de la kératite pneumo- coccique par les sérums et les vaccins. Ann. Inst. Pasteur 39, 685 (1925).

    Google Scholar 

  57. Chapin: Pneumococcus infections. Bull. Ayer clin. Labor. 1925, Nr 9, 16.

    Google Scholar 

  58. Cheney (1): Types of pneumococci found in corneal ulcers. Internat. Congr. Ophthalm. Washington 1922, 378.

    Google Scholar 

  59. Cheney (2): „The common cold“, etiology, prevention and treatment. Amer. J. publ. Health 1928, 15.

    Google Scholar 

  60. Checkering: The concentration of the protective bodies in antipneumococcus serum. J. of exper. Med. 22, 248 (1915).

    Google Scholar 

  61. Chlough, M. C.: A study of pneumococci reacting with antipneumococcus sera of types. I, H a. HI etc. J. of exper. Med. 30, 123 (1919).

    Google Scholar 

  62. Christensen (1): Sur le classement des types des pneumocoques par fixation du complement après absorption. C. r. Soc. Biol. Paris 86, 459 (1922).

    Google Scholar 

  63. Christensen (2): Studies on the pneumococcus types. Kopenhagen 1923.

    Google Scholar 

  64. Christensen (3): Pneumococcus types. Acta path, scand. (Kobenh.) 2, 1 (1925).

    Google Scholar 

  65. Clough, W. P.: The protective power of normal human serum against pneumococci. Bull. Hopkins Hosp. 85, 330 (1924).

    Google Scholar 

  66. Clowes, G. H. A., W. A. Jamteson u. J. S. Olsoni: On a spezific pneumococcus antitoxin. Proc. Soc. exper. Biol. a. Med. 23, 334–337 (1926).

    Google Scholar 

  67. McCltjre, W. St. C.: The incidence of pneumonia. Proc. roy. Soc. Med. 20, Nr 7 (1927).

    Google Scholar 

  68. Cole (1): Etiology of the pneumonias. N. Y. State J. Med. 19, 253 (1919).

    Google Scholar 

  69. Cole (2): Serum treatment in type I lobar pneumonia. J. amer. med. Assoc. 93, 741–747.

    Google Scholar 

  70. Cole u. Moore: The production of antipneumococcic serum. N. Y. State J. Med. 26, 537 (1917).

    Google Scholar 

  71. Conner: Experiences in New York Hospital with the treatment of lobar pneumonia with the serumfree solution of pneumococcus antibodies. Amer. J. med. Sei. 164, 832 (1922).

    Google Scholar 

  72. Cooper, G.: Mucous membrane immunity to pneumococci in rabbits. J. inf. Dis. 38, 419 (1926).

    Google Scholar 

  73. Cooper, G. M, Edwards u. G. Rosenstein: The separation of types among the pneumococci hitherto called group IV and the development of therapeutic antiserum for these types. J. of exper. Med. 49, 461–474 (1929).

    CAS  Google Scholar 

  74. Cotoni: Présence du pneumocoque dans le sang des pneumoniques. Ann. Inst. Pasteur 27, 289 (1913).

    Google Scholar 

  75. Cotoni: u. N. Chambrin: Sur l’immunité passive obtenue à l’aide du pneumocoque III. Ann. Inst. Pasteur 45, 706–726 (1930).

    Google Scholar 

  76. Cotoni: u. Truche: Agglutination des Pneumocoques. Ann. Inst. Pasteur 26, 311 (1912).

    Google Scholar 

  77. Cotoni: u. Raphael (1): Pneumocoques et affections pneumococciques. Monographie Inst. Pasteur. Paris 1922.

    Google Scholar 

  78. Cotoni: (2): The pneumococcus and pneumococcal affections. London 1924.

    Google Scholar 

  79. Coventry, A. Frances: The protective and curative action of large doses of pneumococcus antiserum in mice. Amer. J. Hyg. 7, 515–541 (1927).

    Google Scholar 

  80. Cruveilhier: Action du sérum antipneumococcique au cours de la pneumonie et dans les complications de la grippe. Ann. Inst. Pasteur 33, 448 (1919).

    Google Scholar 

  81. Curphey, Th. I. u. Hermann B. Bajrtjch: A practical method for the immunization of horses by type spezific pneumococcic pleural exudates. Proc. Soc. exper. Biol. a. Med. 26, 687–688 (1929).

    Google Scholar 

  82. Dawson, Martin H. (1): The intereonvertibility of „R“ and „S“ forms of pneumococcus. J. of exper. Med. 47, 577–591 (1928).

    CAS  Google Scholar 

  83. Dawson, Martin H. (2): The transformation of pneumococcal types I. The conversion of R forms of pneumo coccus into S forms of the homologous type. II. The intereonvertibility of type- specific S pneumococci. J. of exper. Med. 51, 99–147 (1930).

    CAS  Google Scholar 

  84. Dawson, Martin H. Oswald T. Avery: Reversion of avirulent „rough“ forms of pneumococcus to virulent „smooth“ types. Proc. Soc. exper. Biol. a. Med. 24, 943–945 (1927).

    Google Scholar 

  85. Dawson, Martin H. u. R. H. P. Sia: The transformation of pneumococcal types in vitro. Proc. Soc. exper. Biol. a. Med. 27, 989–990 (1930).

    Google Scholar 

  86. Dick, Stavely J.: The spezific treatment of pneumonia. Lancet 1925 II, 1110.

    Google Scholar 

  87. Dochez: The presence of protective substances in human serum during lobar pneumonia. J. of exper. Med. 16, 665 (1912).

    CAS  Google Scholar 

  88. Dochez: u. Avery: The occurrence of carriers of desease-producing types of pneumoc. J. of exper. Med. 22, 105 (1915).

    CAS  Google Scholar 

  89. Dubos, R.: The bacteriostatic action of certain components of commercial peptones as affected by conditions of oxidation and reduction. J. of exper. Med. 52, 331–345.

    Google Scholar 

  90. Duchon, L.: La lyso-vaceinothérapie des bronchopneumonies et précisions sur la rôle du bacille de la diphtérie. Presse méd. 1929, 203–206.

    Google Scholar 

  91. Dufourt, A. u. Sédallian, P.: L’étiologie et la prophylaxie des broncho-pneumonies. Presse méd. 1927, 1443.

    Google Scholar 

  92. Egfchi, Ch. (1): Versuche über Infektion und Immunisierung junger und alter Mäuse und Meerschweinchen mit Pneumokokken und Streptokokken durch Fütterung und Inhalation. Z. Hyg. 105, 74 (1925).

    Google Scholar 

  93. Egfchi, Ch. (2): Versuche über Vererbung der Immunität gegen Pneumokokken. Z. Hyg. 105, 265 (1925)..

    Google Scholar 

  94. Enders, J. F.; A type specific substance distinct from the specific carbohydrate in pneumococcus type I. J. of exper. Med. 52, 235–252 (1930).

    CAS  Google Scholar 

  95. Engelmann, Br.: Weiterer Beitrag zur Frage der Einheit der Pneumokokken und Streptokokken. Zbl. Bakter. Orig. 98, 304–307 (1926).

    Google Scholar 

  96. Falk, S. H. u. S. Y. Yang: Studies on respiratory diseases. XXYI. The lysis of pneumo- cocci by sodium oleate. J. inf. Dis. 88, 8–13 (1926).

    Google Scholar 

  97. Falk, S. H. u. S. Y. Yang: u. M. A. Jacobson: Studies on respiratory diseases. XXVIII: The dectrophoretic poten tials, the dissolution and the serum agglutination of pneumococci in the presence of sodium oblate. J. inf. Dis. 38, 188–192 (1926).

    CAS  Google Scholar 

  98. Felton, L. D. (1): A study of the isolation and concentration of the specific antibodies of antipneumococcus sera. Boston med. J. 190, 819–825 (1924).

    Google Scholar 

  99. Felton, L. D. (2): The units of protective antibody in antipneumococcus serum and antibody solu tion. J. inf. Dis. 43, 531–542 (1928).

    CAS  Google Scholar 

  100. Felton, L. D. (3): A method of concentration of pneumococcus antibody. J. inf. Dis. 43, 543 bis 553 (1928).

    CAS  Google Scholar 

  101. Felton, L. D. (4): The protective substance in antipneumococcus serum. J. inf. Dis. 37, 199–224 (1925); 37, 309–320 (1925); 42, 248–255, 256–262 (1928).

    CAS  Google Scholar 

  102. Felton, L. D. (5): The variables in the mouse. Protection test of antipneumococcus serum. J. of Immun. 19, 485–509 (1930).

    Google Scholar 

  103. Felton, L. D. (6): A study of the neutralizing substance of the pneumococcus. J. of Immun. 19, 511–533 (1930).

    Google Scholar 

  104. Felton, L. D. u. G. Howaud Bailey: The immunological characteristics of a water-insoluble protein in type I antipneumococcus sera. J. of Immun. 11, 197–214 (1926).

    CAS  Google Scholar 

  105. Felton, L. D. u. Doughherty: Studies on virulence. I.–III. I. Bull. Hopkins Hosp. 34, 262 (1923); IL/m. J. of exper. Med. 39, 137, 155 (1924).

    Google Scholar 

  106. Felton, L. D. u. Kaufmann, G.: The action of enzymes on the protective antibody of pneumo coccus. J. of Immun. 13 (1927).

    Google Scholar 

  107. Felty, A. R. u. Heathey, C. A.: A clinical and bacteriological study on the nasal passages in lobar pneumonia. J. amer. med. Assoc. 86, 1195 (1926).

    Google Scholar 

  108. Ferguson, R. Fergas, A. F. C. Davey u. W. W. C. Topley: The value of mixed vaccines in the prevention of the common cold. J. of Hyg. 26, 98 (1927).

    CAS  Google Scholar 

  109. Ferri, Umberto: Osservazioni su di una da pneumococco nel lattante. Clin, ed Igiene infant. 4, 471–487 (1929).

    Google Scholar 

  110. Fleming u. Neill: Studies on bacterial enzymes. III. J. of exper. Med. 45, 169 (1927).

    Google Scholar 

  111. Fraenkel, A.: Spezielle Pathologie und Therapie der Lungenkrankheiten. Berlin u. Wien: Urban u. Schwarzenberg 1904. Frankel, A.: Ther. Mh. 1915, 533.

    Google Scholar 

  112. Francis, jr. Th. u. W. S. Tillett: Cutaneous reactions in pneumonia. The development of antibodies following the intradermal injection of type-specific polysaccharide. J. of exper. Med. 52, 573–585 (1930).

    CAS  Google Scholar 

  113. Freedlander, B. L.: The production of potent antipneumococcus serum in rabbits. J. inf. Dis. 43, 137–144 (1928).

    CAS  Google Scholar 

  114. Friedemann, U.: Über die verschiedenen Formen der Pneumonie, ihre Epidemiologie, Pathogenese und Therapie. Med. Klin. 1929, Nr 42.

    Google Scholar 

  115. Gaskel, J. F. (1): Pulmonary lesions due to the pneumococcus. Brit. med. J. 2, 61 (1925).

    Google Scholar 

  116. Gaskel, J. F. (2): Seasonal variation in pneumococcal virulence. J. of Path. 30, 568–569 (1927).

    Google Scholar 

  117. Gaskel, J. F. (3): The pathogenic values of pneumococcal types; The lesions produced in relation to virulence. J. of Path. 31, 613–628 (1928).

    Google Scholar 

  118. Gaspari, L. Emidio., L. William, Fleming u. James M. Neill: Immunological properties of a typical (S-produeing) and a degraded (non-S-produeing) strain of type II pneumococcus with special reference to protective antibodies. J. of exper. Med. 46, 101–111 (1927).

    CAS  Google Scholar 

  119. Gate, J. u. Henri Gardère: Autovaccinothérapie de la pneumonie. Technique rapide. Résultats cliniques. C. r. Soc. Biol. Paris 99, 817–819 (1928).

    Google Scholar 

  120. Gay u. Checkering: Concentration of the protective bodies in antipneumococcus serum etc. J. of exper. Med. 21, 389 (1915).

    Google Scholar 

  121. Gilbert, Ruth u. C. K. Davenport: Failure of the mouse test to demonstrate the presence of type I pneumococcus in sputum. An unusual instance. J. Labor, clin. Med. 12, 944, 945 (1927).

    Google Scholar 

  122. Glyn u. Digby: Bacteriol. and clinical observations on pneumonia etc. Med. Res. a. Council Spec. Rep. Nr 79.

    Google Scholar 

  123. Gondolf, Harold G.: A rapid method for typing in pneumococcal meningitis. Proc. Soc. exper. Biol. a. Med. 24, 295 (1927).

    Google Scholar 

  124. Gonzalez, Ph.: Essais de classification des pneumocoques en Chili. C. r. Soc. Biol. Paris 105, 244–245 (1930).

    Google Scholar 

  125. Goodner, Kenneth (1): Experimental intradermal pneumococcus infection in rabbits. J. of exper. Med. 48, 1–20 (1928).

    CAS  Google Scholar 

  126. Goodner, Kenneth (2): Further experiments with the intradermal pneumococcus infection in rabbits. J. of exper. Med. 48, 413–429 (1928).

    CAS  Google Scholar 

  127. Goodner, Kenneth (3): A method for comparsion of antipneumococcus sera. J. of Immun. 17, 279–283 (1929).

    Google Scholar 

  128. Goodner, Kenneth (4): Experiments on the concentration of antipneumococcic and antimeningococcic horse sera. J. of Immun. 19, 473–483 (1930).

    CAS  Google Scholar 

  129. Gordon The relationship of the pneumococcus to acute infections of the upper respiratory tract in man. J. inf. Dis. 29, 437 (1921).

    Google Scholar 

  130. Gorgas: Recommendation as to sanitation concerning employees of the mines on the rand. Johannisburg 1914.

    Google Scholar 

  131. Gotschlich, E.: Handbuch der Hygiene von Gruber, Rubner u. Eicker, Bd. 3, Abt. 1. 1912.

    Google Scholar 

  132. Gottstein, A.: Rechnende Epidemiologie, in: Ergebnisse der Hygiene, Bakteriologie, herausgeg. von W. Weichardt, Bd. 10. Berlin: Julius Springer 1929.

    Google Scholar 

  133. Mac Gregor, R. Agnes: Acute pneumonia in early childhood. H. Pathology of acute pneumonia in early childhood. Brit. med. J. 1927, 584–589.

    Google Scholar 

  134. Grenet, H.: Traitements spécifiques des bronchopneumonies infantiles. Presse méd. 1927, 1444.

    Google Scholar 

  135. Griffith, Fred. (1): Inhalation experiments on mice with pneumococci. J. of Hyg. 25, 1 (1926).

    CAS  Google Scholar 

  136. Griffith, Fred. (2): The signifance of pneumococcal types. J. of Hyg. 27, 113–159 (1928).

    CAS  Google Scholar 

  137. Grosser, R.: Beitrag zur Pathogenese der croupösen Pneumonie. Z. Kinderheilk. 50, 55–70 (1930).

    Google Scholar 

  138. Grumbach, A. (1): Beitrag zur Frage der Bakterienvariabilität. Schweiz, med. Wschr. 1929.

    Google Scholar 

  139. Grumbach, A. (2): Dissoziationserscheinungen an Pneumokokken. Zbl. Bakter. I Orig. 120, 245–249 (1931).

    Google Scholar 

  140. Gundel, M. (1): Die Enterokokken. Zbl. Bakter. Orig. 109, 384–392 (1928).

    Google Scholar 

  141. Gundel, M. (2): Das biologische System der Streptokokken. Zbl. Bakter. Orig. 115, 44–66 (1929).

    Google Scholar 

  142. Gundel, M. (3): Zur Nomenklatur der Enterokokken und Streptokokken. Zbl. Bakter. Orig. 118, 68–74 (1930).

    Google Scholar 

  143. Gundel, M. (4): Bakteriologie und Klinik seltener Streptokokkeninfektionen. Dtsch. Arch. klin. Med. 168, 129–155 (1930).

    Google Scholar 

  144. Gundel, M. (5): Zur Frage einer Behandlung der Pneumonia crouposa mit Rekonvaleszentenserum. Klin. Wschr. 10, 728–730 (1931).

    Google Scholar 

  145. Gundel, M. (6): Epidemiologie, Pathogenese und spezifische Therapie der Pneumonie. Ref. 14. Yerslg dtsch. Ver.igg Mikrobiol. Heidelberg, 28.–30. Mai 1931. Zbl. Bakter. I Orig. 1931, im Druck.

    Google Scholar 

  146. Gundel, M. u. Seeber, F.: Die klinische Bedeutung der Enterokokken im Magendarmkanal. Dtsch. Arch. klin. Med. 164, 190–201 (1929).

    Google Scholar 

  147. Gundel, M. u. Linden, H. (1): Die Bedeutung des Tierversuches für die bakteriologische Diagnose der Influenza und Pneumonie. Klin. Wschr. 1930, 1402–1405.

    Google Scholar 

  148. Gundel, M. u. Linden, H. (2): Über die Verbreitungsweise der menschlichen Pneumokokkeninfektionen. Z. Hyg. 112, 1–39 (1931).

    Google Scholar 

  149. Gundel, M. u. Linden, H. (3): Experimentelle und epidemiologische Studien zum Influenzaproblem. Arch. f. Hyg. 105, 133–167.

    Google Scholar 

  150. Gundel, M. u. Linden, H. (4): Bakteriologische Untersuchungen an Leichenlungen unter besonderer Berück- sichtigimg ihrer Bedeutung für das Pneumonieproblem. Z. Hyg. 112 (1931), im Druck.

    Google Scholar 

  151. Gundel, M. u. Linden, H. (5): Die Flora der Mundhöhle Gesunder und ihre Bedeutung für die Pathogenese der Erkrankungen der Atmungsorgane. Zbl. Bakter. I Orig. 121, 349 (1931).

    Google Scholar 

  152. Gundel, M. u. Linden, H. u. Ch. Wasu: Die Bedeutung der Virulenz für die Pathogenese menschlicher Pneumo- kokkenerkrankungen. Z. Hyg. 112, 436–462 (1931).

    Google Scholar 

  153. Gutfeld, F. von u.E, Nassau: Die immunbiologische Einstellung gesunder und kranker Kinder gegenüber Pneumokokken. Jb. Kinderheilk. 112; III. F. 62, H. 3/4, 135–148 (1926).

    Google Scholar 

  154. Habbe, Kahl: Zur Bakteriologie bei Lungenentzündungen des Menschen. Dtsch. med. Wschr. 1929 II, 1506–1508.

    Google Scholar 

  155. Haendel, Ludwig u. Ludwig, Lange: Beitrag zum biologischen Verhalten der Pneumokokken. Z. Hyg. 110, 1–21 (1929).

    Google Scholar 

  156. Hallermann, A. u. H. Kahler: Über die Typeneinteilung der Pneumonie und ihre Behandlung mit Serum. Klin. Wschr. 9, Nr 14, 650–652 (1930).

    Google Scholar 

  157. Harkavy, J.: Pneumococcus meningitis, recovery with serum therapy. J. amer. med. Assoc. 90, 597–599 (1928).

    Google Scholar 

  158. Hartwich, A.: Die Behandlung der Pneumonie mit typenspezifischem Serum. Zbl. inn. Med. 1929, 361–367.

    Google Scholar 

  159. Hayhurst, Emery R.: Resistance to pneumococcus infection as influenced by breathing of gas combustion products. Amer. J. publ. Health 1928, 439.

    Google Scholar 

  160. Hazay, L.: Die praktische Bedeutung der Pneumocoeeustypen im Kindesalter. Mschr. ung. Med. 10 (1929).

    Google Scholar 

  161. Heidelberger, Michael, Walther E. Goebel u. Oswald T. Avery: The soluble specific substance of pneumococcus HI. J. of exper. Med. 42, 72 (1925).

    Google Scholar 

  162. Heidelberger, Michael, Walther E. Goebel u. Oswald T. Avery: u. R. H. P. Sia u. E. E. Kendall: Specific precipitation and mouse protection in type I antipneumococcus sera. J. of exper. Med. 52, 477–483 (1930).

    Google Scholar 

  163. Hilgermann, R. (1): Neue Ziele und Wege der Chemotherapie. Münch, med. Wschr. 1930, 1477–1480.

    Google Scholar 

  164. Hilgermann, R. (2): Die Chemotherapie der Pneumokokkeninfektion. Münch, med. Wschr. 1930, 1480. i bis 1483; Z. exper. Med. 74, 232–257 (1930).

    Google Scholar 

  165. Hintze, K.: Untersuchungen und Beobachtungen an Pneumokokken. Zbl. Bakter. I Orig. 99, 419–438 (1926).

    Google Scholar 

  166. Hirsch, A.: Handbuch der historisch-geographischen Pathologie, 2. Aufl. Stuttgart: Ferdinand Enke 1886.

    Google Scholar 

  167. Hughes, T. P.: Acid agglutination zones of typical and variant pneumococci. Proc. Soc. , exper. Biol. a. Med. 27, 804–809 (1930).

    Google Scholar 

  168. Huntoon, F. M.: Pneumococcus antibody solution. J. Labor, clin. Med. 11, 759–762 (1926).

    Google Scholar 

  169. Julianelle, L. A.: Reactions of rabbits to intracutaneous injections of pneumococci and their products. I–VI. J. of exper. Med. 51, 441–657 (1930).

    CAS  Google Scholar 

  170. Julianelle, L. A.: u. O. T. Avery: Intracutaneous vaccination of rabbits with pneumpcoccus I–HI. Proc. Soc. exper. Biol. a. Med. 26, 224r-225, 226–227, 227–229 (1928).

    Google Scholar 

  171. Kapsinow, R.: Acute pneumococcus endocarditis following extraction of teeth. J. amer. med. Assoc. 95, 409 (1930).

    Google Scholar 

  172. Kimura, R.: Weitere Versuche über aktive Immunisierung per os gegen Pneumokokken. Z. Hyg. 107, 390–395 (1927).

    Google Scholar 

  173. Kimura, R.: Sukneff u. Hans Meyer: Auftreten verschiedener Varianten von Pneumokokken bei Züchtung im Immunserum. Z. Hyg. 109, 51–77 (1928).

    Google Scholar 

  174. Kirchhoff, H.: Pneumokokkenperitonitis. Zbl. Chir. 1930, Nr 35.

    Google Scholar 

  175. Kleinschmidt, H.: Verschiedene Pneumokokkentypen unter Optochineinwirkung. Klin. Wschr. 1930, Nr 8, 357–358.

    Google Scholar 

  176. Kneeland jr. Yale: Studies on the common cold. IH. J. of exper. Med. 51, 617–624 (1930).

    CAS  Google Scholar 

  177. Kolle, W. u. H. Hetsch: Die experimentelle Bakteriologie und die Infektionskrankheiten. I. u. IL, 7. Aufl. Berlin u. Wien: Urban u. Schwarzenberg 1929.

    Google Scholar 

  178. Konn, L. u. Raftdison: Vaccinotherapie et vaecinoprophylaeie antipneumocoeeique a Tanarive. Bull. Soc. Path. exot. Paris 19, 521–528 (1926).

    Google Scholar 

  179. KramAr, E. u. D. Gyüre: Untersuchungen über die Immunbiologie der Lungenentzündungen. I. Pneumokokkentypen und Hautreaktion. II. Pneumokokkenhautreaktion und humorale Antikörper. III. Mechanismus und immunbiologische Bedeutung der Pneumokokkenhautprobe. IV. Die experimentelle Pneumonie. Arch. Kinderheilk. 39, 73–96 (1929); 91, 278–283 (1930).

    Google Scholar 

  180. Kruse: Ursachen der Lungenentzündung. Zbl. allg. Gesdh.pfl. 32, 303–338 (1913).

    Google Scholar 

  181. Lambert, A.: Use of mixed stock vaccine in pneumonia. J. amer. med. Assoc. 87, 56 (1926).

    Google Scholar 

  182. Larson, W. P.: A report on the preparation of pneumococcic antitoxin. Proc. Soe. exper. Biol. a. Med. 28, 497–498 (1926).

    Google Scholar 

  183. Larson u. Nelson: The antigenic properties of pneumoeocci and streptococci treated with sodium ricinoleate. Proc. Soc. exper. Biol. 22, 357 (1925).

    Google Scholar 

  184. Lauche, A. (1): Über das Problem der lobären Pneumonie vom Standpunkt des Pathologen. Klin. Wschr. 1928 II, 2421–2424.

    Google Scholar 

  185. Lauche, A. (2): Die Entzündungen der Lunge und des Brustfells. Handbuch der speziellen patho logischen Anatomie und Histologie, herausgeg. von E. Henke u. O. Lubarsch, Bd. 3, I. Teil, S. 531–898. Berlin: Julius Springer 1928.

    Google Scholar 

  186. Lechner, A.: Die spezifische Serumbehandlung der Pneumonie. Klin. Wschr. 1928, 1325 bis 1327.

    Google Scholar 

  187. Lederer, R.: Der Wintergipfel der Atmungserkrankungen I und H. Z. Kinderheilk. 46, 723–747 (1928).

    Google Scholar 

  188. Lehmann, Hans (1): Die Bedeutung der Lungenentzündung als Todesursache. Arch. f. Hyg. 95, 40–68 (1924).

    Google Scholar 

  189. Lehmann, Hans (2): Weitere Betrachtungen über die Lungenentzündung als Todesursache. Arch. f. Hyg. 102, 203–226 (1929).

    Google Scholar 

  190. Lessne, E., Marquézy, Héraux u. Stieffel: La thérapie des bronchopneumonies. Presse méd. 1927, 1445.

    Google Scholar 

  191. Leventhal, W.: Umwandlung avirulenter Pneumokokken in virulente. Klin. Wschr. 1926, 2020–2021, Nr 43.

    Google Scholar 

  192. Lévy u. Brühl: Recherches sur le pneumocoque HI (Pneumococcus mucosus). Origine, caractères généraux et virulense de 20 échautillons. Ann. Inst. Pasteur 41, 458–472 (1927).

    Google Scholar 

  193. Lichtenstein, H.: Die Serumbehandlung der eroupösen Pneumonie. Med. Klin. 1929, 1966.

    Google Scholar 

  194. Lister: Prophylactic inoculation of man against pneumococcal infections. S. afric. med. Res. 1917, Nr 10.

    Google Scholar 

  195. Liston, W. G.: Note on the bacteriology of bronchopneumonia of children. Arch. Dis.Childh. 4, 283–290 (1929).

    PubMed  CAS  Google Scholar 

  196. Loeschcke (1): Die Pathologie der Kinderpneumonien. Mschr. Kinderheilk. 41, 135–152.

    Google Scholar 

  197. Loeschcke (2): Untersuchungen über die eroupöse Pneumonie. Beitr. path. Anat. 86, 201–223 (1931).

    Google Scholar 

  198. Loewy, G. Analyse chimique des bactéries et aspects chimiques de l’immunité. Presse méd. 1929, 752–753.

    Google Scholar 

  199. van Loghem, J. J. (1): Epidemiologische bijdrage tot de Kennis van de ziekten der adem- halingsorganen. Nederl. Tijdschr. Geneesk. 1, 6 (1928).

    Google Scholar 

  200. van Loghem, J. J. (2): An epidemiological contribution to the knowledge of the respiratory diseases. J. of Hyg. 28, 33–54 (1928).

    Google Scholar 

  201. Lord, F. T. u. G. E. Nesche: Antibody and agglutinin in pneumococcus pneumonia. J. of exper. Med. 50, 449–453 (1929).

    CAS  Google Scholar 

  202. Lord, F. T. u. E. L. Persons.* Certain aspects of mouse protection tests for antibody in pneumo coccus pneumonia. J. of exper. Med. 53, 151–158 (1931).

    CAS  Google Scholar 

  203. Lungsgaard: Pneumococcus types and the incidence of pneumococci on the normal conjunctiva. Comm. Inst. Sérothér. Danois 1924, 15.

    Google Scholar 

  204. Lyon: Bacteriological studies of 165 cases of pneumonia. Amer. J. Dis. Childr. 23, 72 (1922).

    Google Scholar 

  205. Maeji, J. (1): Studien über die Pneumokokken. I. Versuche in vivo. II. Versuche über die orale Immunisierung junger Tiere mit dem Pneumokokkentypus III. HI. Wirkungen der Chemikalien auf die Pneumokokken. Acta Scholae med. Kioto 12,295–301, 405–413, 415–423 (1929).

    Google Scholar 

  206. Maeji, J. (2): Das Pneumokokkenantivirus. I. Versuche an Mäusen und Meerschweinchen. Z. Immun.forschg 65, 35–40 (1930). H u. III. Acta Scholae med. Kioto 12, 425–440, 441–443 (1930).

    Google Scholar 

  207. Malone: A note on a series of cases of pneumonia treated with pneumococcus vaccine. Indian J. med. Res. 12, 105 (1924).

    Google Scholar 

  208. Marginescu u. Corda: Studi sui pneumococchi II. Atti Accad. Eisiocritici Siena 15, 1 (1924).

    Google Scholar 

  209. Means, J. W.: The incidence of pneumococcus types in pneumonia in Pittsburgh. Atlantic med. J. 30, 499–503 (1927).

    Google Scholar 

  210. Meyer, Eritz (1): Die Pneumokokkenserumtherapie in: Handbuch der experimentellen Therapie, Serum- und Chemotherapie. Ergänzungsband von A. Wolff - Eisner. München 1931.

    Google Scholar 

  211. Meyer, Eritz (2): Die spezifische Behandlung der Pneumokokkenpneumonie. Ther. Gegenw. 7 (1930). Meyer, H.: Über aktive Immunisierung von Mäusen durch in Na. taurocholic. gelöste Pneumokokken. Z. Hyg. 107, 416 (1927).

    Google Scholar 

  212. Meyer, Eritz u. Sukneff, W. W.: Über die immunisierende Wirkung von avirulenten Pneumokokken und von Kulturfiltraten und Auflösungen virulenter Pneumokokken. Z. Hyg. 109, 78–92 (1928).

    Google Scholar 

  213. Meyer, L. F.: Die Lungenentzündungen im frühen Kindesalter. Z. ärztl. Fortbildg 1931, 37–40.

    Google Scholar 

  214. Moore: A note on the types of pneumococci causing acute lobar pneumonia in Dublin. Ir. J. med. Sei. 5, 1 (1923).

    Google Scholar 

  215. Müller: Auftreten und Bedeutimg von bacterieiden Schutzstoffen des Blutes im Verlaufe der kruppösen Pneumonie. Z. Hyg. 97, 26 (1923).

    Google Scholar 

  216. Nakajima, H.: Experimental studies on the pneumococcus immunisation by intratracheal route. Sei. Rep. Gov. Inst. inf. Dis. Tokyo Univ. 6, 97–109 (1927).

    Google Scholar 

  217. Nakajwura, M.: Etude expérimentale sur l’inflammation de l’organe d’ouie provoquée par le diplocoque de la pneumonie. Fukuoka-Ikwadaigaku-Zasshi (jap.) 20, 823–850 (1927).

    Google Scholar 

  218. Neil, Charles: Acute pneumonia in early childhood. I. Incidance and mortality of the disease in early infancy. Brit. med. J. 1927, 582–584, 587–589.

    Google Scholar 

  219. Neufeld (1): Neue Forschungsergebnisse über Pneumonie. Dtsch. med. Wschr. 1922, Nr 2.

    Google Scholar 

  220. Neufeld (2): Über die Veränderlichkeit der Krankheitserreger. Dtsch. med. Wschr. 1924, Nr 1; Zbl. Bakter. Orig. 93, Beih. 41 (1924).

    Google Scholar 

  221. Neufeld u. Meyer: Über die Bedeutung des Reticoloendothels für die Immunität. Z. Hyg.

    Google Scholar 

  222. 103, 595 (1924).

    Google Scholar 

  223. Neufeld u. Ungermann: Über experimentell erzeugte Pneumonien und ihre Beeinflussung durch Antipneumokokkenserum. Zbl. Bakter. Ref. 54, Beih., 71 (1912); Berl. klin. Wschr. 1911, 717, 1010.

    Google Scholar 

  224. Neufeld u. Leventhal, W.: Beiträge zur Variabilität der Pneumokokken. Z. Immun.forschg

    Google Scholar 

  225. 55,324–340 (1928).

    Google Scholar 

  226. Neufeld u. Schnitzer, R.: Pneumokokken. Handbuch der pathogenen Mikroorganismen von W. Kolle, R. Kraus u. P. Uhlenhuth, Bd. 4. 1928.

    Google Scholar 

  227. Neufeld u. Etinger-Tulczynska, R.: Untersuchungen zur Gallenlösung der Pneumokokken. Arch. f. Hyg. 103, 107–123 (1930).

    Google Scholar 

  228. Neumann, R. u. H. Happe: Zur Bakteriologie und spezifischen Prophylaxe der Säuglings- pneumonie. Msehr. Kinderheilk. 45, 141–151 (1929).

    Google Scholar 

  229. Nicholls u. Spaeth: The relation between fatigue and the susceptibility of guineapigs to infections of type I pneumococcus. Amer. J. Hyg. 2, 527 (1922).

    Google Scholar 

  230. Nicolau, J. u. Sédallian, P.: Répartition des pneumocoques dans pneumococcie expérimentale de la souris blanche. C. r. Soc. Biol. Paris 98, 708–710 (1928).

    Google Scholar 

  231. Nobécourt u. Paraf: Étude des pneumocoques isolés dans une crèche d’hôpitale. Bull. Soc. Méd. Paris 43, 687 (1919).

    Google Scholar 

  232. Odell, H. R.: Observations on the standardization of antipneumococcus serum by the protection test. J. of Immun. 18, 73–85 (1930).

    Google Scholar 

  233. d’Oelsnitz: La séro-vaccinothérapie des bronchopneumonies de l’adulte et de l’enfant d’après 200 cas observés en 4 ans. Presse méd. 1926, 506.

    Google Scholar 

  234. Oijver (1): A rapid method of pneumococcus typing. J. inf. Dis. 31, 1920 (1927).

    Google Scholar 

  235. Oijver (2): Further observations on a rapid method of pneumococcus typing. J. inf. Dis. 29,

    Google Scholar 

  236. (1921).

    Google Scholar 

  237. Olmstead: An antigenic classification of the group IV pneumococci. J. of Immun. 2, 425 (1917).

    CAS  Google Scholar 

  238. Olson, J. G. (1): Studies on a spezific pneumococcus toxin. Proc. Soc. exper. Biol. a. Med. 23, 295 (1926).

    Google Scholar 

  239. Olson, J. G. (2): Further studies on a specific pneumococcus toxin. Proc. Soc. exper. Biol. a. Med. 23, Nr 5, 331–334 (1926).

    Google Scholar 

  240. Parish, H. J.: The titration of antipneumococcus serum. J. of Path. 33, 729–-737 (1931).

    Google Scholar 

  241. Park, W. H. (1): Value of the newly identified types in the study of the epidemiology of pneumoeoeeus infections. Amer. J. publ. Health 20, 403–407 (1930).

    CAS  Google Scholar 

  242. Park, W. H. (2): Pneumonia. I. The types of pneumococci in adults and children and their significance. J. State Med. 38, 621–637 (1930).

    Google Scholar 

  243. Park, W. H. (3): Pneumonia H. J. State Med. 39, 1–25 (1931).

    Google Scholar 

  244. Park, W. H. (4): Pneumonia. J. State Med. 39, 3–27 (1931).

    Google Scholar 

  245. Park, W. H. u. Checkering: Type I Pneumoeoeeus lobare pneumonia…. J. amer. med. Assoc. 73, 183 (1919).

    Google Scholar 

  246. Park, W. H. u. Cooper, G.: Antipneumococcus serum in lobar pneumonia. Method of administration and dosage. J. amer. med. Assoc. 90, 1349–1351 (1928).

    Google Scholar 

  247. Park, W. H. Bullowa u. Rosenblüth: The treatment of lobar pneumonia with refined specific antibacterial serum. J. amer. Assoc. 91, 1503–1508 (1928).

    Google Scholar 

  248. Parker, J. T. (1): The production of skin necrosis by certain antolysates of pneumoeoeeus (types I und H). J. of exper. Med. 47, 531 (1928).

    CAS  Google Scholar 

  249. Parker, J. T. (2): Experimental pneumonia in guinea pigs. II. Effect of antiautolysate sera on pneumoeoeeus in guinea pigs. J. of exper. Med. 50, 161–169 (1929).

    CAS  Google Scholar 

  250. Parker, J. T. u. van Coy M.: The production and titration of potent horse antipneumotoxin. J. of exper. Med. 50, 103–107 (1929).

    CAS  Google Scholar 

  251. Parker, J. T. u. A. M. Pappenheimer: Experimental pneumonia in guinea pigs. I. The effect of certain toxic antolysates of pneumococci. J. of exper. Med. 48, 695–707 (1928).

    CAS  Google Scholar 

  252. Paul, J. R. (1): A comperative study of smooth and rough pneumoeoeeus colonies. J. of exper Med. 46, 793 (1927).

    CAS  Google Scholar 

  253. Paul, J. R. (2): The occurrence of rough pneumococci in vivo. J. of exper. Med. 46, 807–817 (1927).

    CAS  Google Scholar 

  254. Pearl: The constitutional element in the etiology of pneumonia. Proc. Soc. exper. Biol. a. Med. 23, 573–576 (1926).

    Google Scholar 

  255. Pieper: Streptokokken und Pneumokokken. Zbl. Hyg. 3, 433 (1923). Pierce, C. C.: Hospitalization of pneumonia cases. Modern Hosp. 25, 487–492 (1925).

    Google Scholar 

  256. Pittman, Majrgaret u. S. S. Ealk: Studies on respiratory diseases. XXXIV. Some relations of pneumococci. XXXV. The pathology of pneumoeoeeus infections. J. Bacter. 19, 327–361, 363–374 (1930).

    Google Scholar 

  257. Pockels, W.: Immunbiologische Studien bei Pneumokokkeninfektionen. Mschr. Kinder- heilk. 40, 238–250 (1928).

    Google Scholar 

  258. Powell, J. P., R. M. Atwater u. L. D. Eelton: The epidemiology of pneumonia. A study of pneumoeoeeus carriers among four groups of persons over a period of months. Amer. J. Hyg. 6, 570–592 (1926).

    Google Scholar 

  259. Prausnitz, C.: Die Standardisierung von Heilseren, serologischen Reaktionen und Impf- stoffen. Erg. Hyg. 10, herausgeg. von W. Weichhardt. Berlin: Julius Springer 1929.

    Google Scholar 

  260. Quiroga, R.: Kulturböden mit Leberextrakt zur Kultur des Pneumoeoeeus.. Rev. Soc. argent. Biol. 4, 491–495 (1928); C. r. Soc. Biol. Paris 99, 1517–1519 (1928).

    Google Scholar 

  261. Rakieten, M. L.: A variant obtained directly from pneumoeoeeus Type II. ’ J. Bacter. 20, 1–7 (1930).

    CAS  Google Scholar 

  262. Reimann, Hobart A. (1): Serological relationships of hypospeeifie and degraded pneumo- cocci. J. of exper. Med. 43, 107 (1926).

    CAS  Google Scholar 

  263. Reimann, Hobart A. (2): Studies concerning the relationship between pneumococci and streptococci. J. of exper. Med. 45, 1–10 (1927).

    CAS  Google Scholar 

  264. Reimann, Hobart A. (3): The occurrence of degraded pneumococci in vivo. J. of exper. Med. 45, 807–814 (1927).

    CAS  Google Scholar 

  265. Reimann, Hobart A. (4): The reversion of R- to S-pneumococcus. J. of exper. Med. 49, 237–249. (1929)

    CAS  Google Scholar 

  266. Rich, A. R. and J. H. Brown: Dissociation of allergy from immunity in Pneumoeoeeus

    Google Scholar 

  267. infection. Proc. Soc. exper. Biol. a. Med. 27, 695–696 (1930).

    Google Scholar 

  268. Riddervold, J.: Pneumonia crouposa epidemia. Norsk Mag. Laegevidensk. 91, 731–738. (1930)

    Google Scholar 

  269. Rimpau, W.: Über das Problem der Entstehung der Erkältungskrankheiten. Münch, med. Wschr. 1930, Nr 48 u. 49, 2065 u. 2102.

    Google Scholar 

  270. Robertson, O. H., S. T. Woo, S. N. Cheer, L. P. King: A study of the mechanism of recovery from experimental pneumococcus infection. J. of exper. Med. 47, 317–343. (1928)

    CAS  Google Scholar 

  271. Robertson, O. H., S. T. Woo, S. N. Cheer, L. P. King: u. Sia: The relation of opsonins to natural resistance against pneumococci. J. of exper. Med. 46, 239 (1927).

    CAS  Google Scholar 

  272. Robertson, O. H., S. T. Woo, S. N. Cheer, L. P. King: u. M. A. Cornwell: A study of the resistance of normal human beings to recently isolated strains of pathologic pneumococci. J. of exper. Med. 52, 267–277 (1930).

    CAS  Google Scholar 

  273. Robertson, O. H., S. T. Woo, S. N. Cheer, L. P. King: E. E. Terrel, J. B. Graeser and M. A. Cornwell: The relation of natural antipneumo- coccal immunity to the inception of lobar pneumonia. J. of exper. Med. 52, 421–433 (1930).

    CAS  Google Scholar 

  274. Robinson, G. H.: The immunologic relations of type IV pneumococci obtained during an epidemie. J. inf. Dis. 41, 417–422 (1927).

    Google Scholar 

  275. Rogers, L.: Relationship between pneumonia incidance and climate in India. Lancet 19251 1173.

    Google Scholar 

  276. Römer: Experimentelle und klinische Grundlagen für die Serumtherapie der Pneumo-

    Google Scholar 

  277. kokkeninfektion der menschlichen Cornea. Wiesbaden 1909.

    Google Scholar 

  278. Rosenau, M. J., L. D. Eelton u. R. M. Atwater: An epidemiologic study of pneumonia and its mode of spread. Amer. J. Hyg. 6, 463–483 (1926).

    Google Scholar 

  279. Rosenblüth, M. B.: Relation of bacteremia in lobarpneumonia to prognosis and therapy. J. amer. med. Assoc. 90, 1351–1353 (1928)

    Google Scholar 

  280. Ross, V. (1): Immunity to pneumococcus produced in rats by feeding tissues of animals killed by the same organism. J. of Immun. 12, 219, 237, 323 (1926); Proc. Soc. exper. Biol. a. Med. 24, 273 (1926).

    Google Scholar 

  281. Immunity against pneumococcus afforded rats by feeding tissues of animals killed by the same germ. Proc. Soc. exper. Biol. a. Med. 28, 183 (1925); 1926, 322.

    Google Scholar 

  282. Oral immunization of rats against pneumococcus types II and III. Proc. Soc. exper. BioI. a. Med. , 697 (1927)

    Google Scholar 

  283. Imunization against pneumococcus by feeding desiccated or milksuspended organismus. Proc. Soc. exper. Biol. a. Med. 20, 142-144 (1927)

    Google Scholar 

  284. Oral immunization experiments with disrupted, dissolved and avirulent pneumococci.Time of appearance of immunity. Proc. Soc. exper. Biol. a. Med. 26, 565-567 (1929).

    Google Scholar 

  285. Oral immunization experiments with disrupted, dissolved and avirulent pneumococci.Time of appearance of immunity. Proc. Soc. exper. Biol. a. Med.26 , 565-567 (1929).

    Google Scholar 

  286. Ross, V. (2): Immunity against pneumococcus afforded rats by feeding tissues of animals killed by the same germ. Proc. Soc. exper. Biol. a. Med. 23, 183 (1925); 1926, 322.

    Google Scholar 

  287. Ross, V. (3): Oral immunization of rats against pneumococcus types II and III. Proc. Soc. exper. Biol. a. Med. 24, 697 (1927).

    Google Scholar 

  288. Ross, V. (4): Imunization against pneumococcus by feeding desiccated or milk suspended Organismus. Proc. Soc. exper. Biol. a. Med. 25, 142–144 (1927).

    Google Scholar 

  289. Ross, V. (5): Oral immunization experiments with disrupted, dissolved and avirulent pneumo cocci. Time of appearance of immunity. Proc. Soc. exper. Biol. a. Med. 26, 565–567.

    Google Scholar 

  290. Ross, V. (6): Oral Immunization against the pneumococcus, Use of bile salt dissolved organisms, etc., time of appearance of immunity and dosage. J. of exper. Med. 51, 585–607.

    Google Scholar 

  291. Ross, V. (7): Effect of feeding specific polysaccharide on resistance to pneumococcus. Proc. Soc. exper. Biol. a. Med. 27, 658–660 (1930).

    Google Scholar 

  292. Sabin, A. B. (1): The „stained slide“ microscopic agglutination test: application (I) rapid typing of pneumococci; (n) determination of antibody. Proc. Soc. exper. Biol. a. Med. 26, 492–494 (1929).

    Google Scholar 

  293. Sabin, A. B. (2): The „stained slide“ microscopic agglutination test. Its application to (I) rapid

    Google Scholar 

  294. typing of pneumococci; (H) determination of antibody. Amer. J. publ. Health 19, 1148–1150 (1930).

    Google Scholar 

  295. Sabin, A. B. U. G. B. Wallace: A method for determining the ehillprodueing properties of anti- pneumococci serum. Proc. Soc. exper. Biol. a. Med. 27, 198–199 (1929).

    Google Scholar 

  296. Saito, T. U. W. Olrich: Über die Gewinnung des spezifischen Kohlehydrates der H-Pneumo- kokken und seine chemischen Eigenschaften. Z. Hyg. 109, 163–169 (1928).

    Google Scholar 

  297. Samsoen, J. U. S. Dreyfus: Essais de prophylaxie et de traitement de la bronchopneumonia par les vaccins polymierobiens. Presse méd. 1927, 341.

    Google Scholar 

  298. Sassoon, E.: A note on the use of an organic sulphur compound in coccal infections. Lancet 1930,I, 183.

    Google Scholar 

  299. Schaudig, H.: Zur Diagnose und Behandlung der kindlichen Diplokokkenperitonitis. Dtsch. Z. Chir. 229, 295–302 (1930).

    Google Scholar 

  300. Schiemann, Oscar (1): Die Beziehungen zwischen Typenspezifität, -virulenz und Pathogenität bei Pneumokokken. Z. Hyg. 110, 175–181 (1929).

    Google Scholar 

  301. Schiemann, Oscar (2): Weitere Untersuchungen mit dem Kohlehydrat aus Typ II-Pneumokokkén. Z. Hyg. 110, 567–580 (1929).

    CAS  Google Scholar 

  302. Schiemann, Oscar U. W. Casper: Sind die spezifisch präzitablen Substanzen der 3 Pneumokokkentypen Haptene? Z. Hyg. 108, 220–257 (1927). 264 M. Gundel:

    Google Scholar 

  303. Schiemann, Oscar, H. Loewenthal u. H. Hackenthal: Über die immunisierende und shockerzeugende Wirkung von C - haltigen Fraktionen, gereinigter C-Substanz und Lipoiden aus Pneumokokken. Z. Hyg. 112, 315–331 (1931).

    CAS  Google Scholar 

  304. Schnabel: Die Blutgifte der Pneumokokken. Z. Hyg. 93, 157 (1921).

    Google Scholar 

  305. Schiemann, Oscar U. Kasarnowsky: Über Empfindliehkeitsversuehe an Bakterien im infizierten Organis mus. Klin. Wsehr. 1923, Nr 15.

    Google Scholar 

  306. Schnitzer U. Berger: Über die Wirkungsweise des Optoehins gegenüber Pneumokokken. Zbl. Bakter. Orig. 93, Beih., 292 (1924).

    CAS  Google Scholar 

  307. Schnitzer U. Munter: Zustandsänderungen der Streptokokken im Tierkörper. I–IH. Z. Hyg. 93, 96 u. 94, 107 (1921); 99, 366 (1923).

    Google Scholar 

  308. Schöbl, O. U. Sellards: Experimental pneumonia in monkeys. Philippine J. Sci. 31, 1–32 (1926).

    Google Scholar 

  309. Schottmüller: Zur Frage der Serumbehandlung bei Pneumonia erouposa. Dtseh. med. Wsehr. 1930, 863.

    Google Scholar 

  310. Seitz, A.: Die Pneumokokken in der Umgebung Gesunder und Kranker. Klin. Wsehr. 1922, 2369.

    Google Scholar 

  311. Seligmann: Versuche zur Deutung der pneumonischen Krise. Z. Immun.forsehg 9, 78 (1911).

    CAS  Google Scholar 

  312. Seyderhelm, R.: Die Behandlung der Lungenentzündung. Med. Welt 1930, 1610–1612, 1649–1651.

    Google Scholar 

  313. Sharp, E. A. and Fr. G. Blake: Host factors in the pathogenesis of pneumococcus pneumonia. I. J. of exper. Med. 52, 501–517 (1930).

    CAS  Google Scholar 

  314. Shibley, G. S., K. S. Mills U. A. R. Dochez: Studies on the etiology of the common cold. J. amer. med. Assoc. 95, 1553–1556 (1930).

    Google Scholar 

  315. Sia, R. H. P.: The susceptibility of hamsters and white mice to pneumococcus infections. Nat. med. J. China 16, 65–67 (1930).

    Google Scholar 

  316. Sia, R. H. P.: Robertson, O. H. U. S. T. Woo: A study of the machanism of recovery from lobar pneumonia. J. of exper. Med. 48, 513–532 (1928).

    CAS  Google Scholar 

  317. Sickles, G. M.: The comperative potency of concentrated and unconcentrated antipneumo- coccus serum. J. inf. Dis. 45, 490–494 (1929).

    Google Scholar 

  318. Silberstein, W.: Zur Frage der Variabilität in der Streptokokken-Pneumokokkengruppe. Z. Hyg. 107, 725–730 (1927).

    Google Scholar 

  319. Simpson, A. S.: A case of pneumococcal meningitis with complate recovery following serum treatment. Lancet 1927 I, 390.

    Google Scholar 

  320. Singer U. Adler (1): Zur Frage der Pneumokokkenimmunität. Z. Immun.forsehg 41, 468 (1924).

    Google Scholar 

  321. Singer U. Adler (2): Immunität gegen Pneumococcus Typ IH. Z. Immun.forsehg 41, 71 (1924).

    Google Scholar 

  322. Smillie, W. G. U. E. L. Caldwell: A study of pneumonia in a rural area in Southern Alabama. J. of exper. Med. 50, 233–244 (1929).

    CAS  Google Scholar 

  323. Sonnenfeld, A.: Serumtherapie der croupösen Pneumonie. Dtseh. med. Wsehr. 1930, 569–571.

    Google Scholar 

  324. Staehelin, R.: Die Erkrankungen der Trachea, der Bronchien, der Lungen und der Pleuren. Handbuch der inneren Medizin, herausgeg. von G. v. Bergmann u. R. Staehelin, Bd. 2, 2. Hälfte. Berlin: Julius Springer 1930.

    Google Scholar 

  325. Stewart, F. W. (1): Local specific treatment of experimental pneumococcus meningitis. J. amer. med. Assoc. 89, 1316 (1927).

    Google Scholar 

  326. Stewart, F. W. (2): Local specific therapy of experimental pneumococcus meningitis. I. H. III. IV. J. of exper. Med. 46, 391 u. 409 (1927); 47, 1–7, 515–530 (1928).

    CAS  Google Scholar 

  327. Stillman, E. G. (1): Contribution to the epidemiology of lobar pneumonia. J. of exper. Med. 24, 651 (1916).

    CAS  Google Scholar 

  328. Stillman, E. G. (2): Further studies on the epidemiology of lobar pneumonia. J. of exper. Med. 26, 513 (1917).

    CAS  Google Scholar 

  329. Stillman, E. G. (3): Presence of bacteria in the lungs of mice. J. of exper. Med. 40, 117 u. 353 (1924).

    Google Scholar 

  330. Stillman, E. G. (4): Production of immunity in mice by inhalation of pneumococci. J. of exper. Med. 40, 567 (1924).

    CAS  Google Scholar 

  331. Stillman, E. G. (5): A study of atypical type H pneumococci. J. of exper. Med. 29, 251 (1919).

    Google Scholar 

  332. Stillman, E. G. (6: The development of agglutinins and protective antibodies in rabbits following inhalation of pneumococci. J. of exper. Med. 45, 1057 (1927).

    CAS  Google Scholar 

  333. Stillman, E. G. (7): The effect of the route of immunisation on the immunity response to pneumoeoccus type I. J. of exper. Med. 50, 721–727 (1930).

    Google Scholar 

  334. Stillman, E. G. (8): Development of agglutinins and protective antibodies in rabbits, after inhalation of type H pneumocoeci. J. of exper. Med. 52, 225–234 (1930).

    CAS  Google Scholar 

  335. Stillman, E. G. (9): Susceptibility of rabbits to infection by the inhalation of type II pneumococci. J. of exper. Med. 52, 215–224 (1930).

    CAS  Google Scholar 

  336. Stillman, E. G. U. Branch, A. (1): Susceptibility of rabbits to infection by the inhalation of virulent pneumococci. J. of exper. Med. 44, 581 (1926).

    CAS  Google Scholar 

  337. Stillman, E. G. U. Branch, A. (2): Early pulmonary leasions in partially immune alcoholizied mice following inhalation of virulent pneumococci. J. of exper. Med. 51, 275–283 (1930).

    CAS  Google Scholar 

  338. Stryker: Variations in the pneumococcus induced by growth in immune serum. J. of exper. Med. 24, 49 (1916).

    CAS  Google Scholar 

  339. Stull, A.: A chemical study of type III pneumococci. J. biol. Chem. 82, 641–650 (1929).

    CAS  Google Scholar 

  340. Stuppy, G. W. U. J. S. Falk: The immunization of rabbits against experimental pneumococcus infections. J. of prevent. Med. 2, 175–189 (1928).

    Google Scholar 

  341. Stuppy, G. W. U. J. S. Falk: U. Cannon, P. R.: Nature of local immunity in lungs of rabbits immunized against pneumococci. Proc. Soc. exper. Biol. a. Med. 26, 314–316 (1929).

    Google Scholar 

  342. Sugg, J. Y., L. V. Richardson U. J. M. Neill: Studies on immunological relationships among the pneumococci IV. J. of exper. Med. 50, 579–581 (1929).

    CAS  Google Scholar 

  343. Sutliff, W. D. (1): An investigation of the reliability of sputum typing for pneumococcus by mouse method. J. inf. Dis. 42, 485–490 (1928).

    Google Scholar 

  344. Sutliff, W. D. (2): Agglutinins and protective bodies in Pneumococcus immunity and application to the control of specific therapy. Proc. Soc. exper. Biol. a. Med. 25, 292 (1928).

    Google Scholar 

  345. Sutliff, W. D. (3): Constitutional reactions immediately after injection of concentrated serum. J. of Allergy 1, 156 (1930).

    Google Scholar 

  346. Sutliff, W. D. U. D. R. Rhoades: The pneumocoeeidal power of whole blood. I. J. clin. Invest. 9, 43–53 (1930); II. 9, 55–68 (1930).

    CAS  Google Scholar 

  347. Sutton, D. C.: Vaccine therapy. Illinois med. J. 53, 280–282 (1928).

    Google Scholar 

  348. Sygenstricker u. Sutton: Bull. J. Hopkins Hosp. 28, 312 (1917).

    Google Scholar 

  349. Takami: Über ein neues Verfahren, gut wirkende Pneumokokkensera herzustellen. Tohoku J. of exper. Med. 6, 65 (1925).

    Google Scholar 

  350. Tani: Beiträge zur aktiven Immunisierung gegen Pneumokokken. Z. Hyg. 103, 204 (1924).

    Google Scholar 

  351. Terrell, E. E.: Changes in humoral immunity occurring during the early of experimental pneumococcus infection. J. of exper. Med. 51, 425–440 (1930).

    CAS  Google Scholar 

  352. Terrell, E. E.: U. O. H. Robertson: Production of experimental lobar pneumonia in the dog. Proc. Soc. exper. Biol. a. Med. 27, 973–975 (1930).

    Google Scholar 

  353. Thomsen U. Christensen: Contribution à la connaissance des types de pneumocoque. C. r. Soc. Biol. Paris 84, 327 (1921).

    Google Scholar 

  354. Tillett, W. S. (1): Studies on immunity to pneumococcus mucosus (type HI). I. II. III. J. of exper. Med. 45, 713, 1093 (1927); 46, 343–356 (1927).

    CAS  Google Scholar 

  355. Tillett, W. S. (2): Active and passive immunity to pneumococcus infection induced in rabbits by immunization with R pneumococci. J. of exper. Med. 48, 791–804 (1928).

    CAS  Google Scholar 

  356. Tillett, W. S. W. F. Goebel U. O. T. Avery: Chemical and immunological properties of a species- specific carbohydrate of pneumococci. J. of exper. Med. 52, 895–900 (1930).

    CAS  Google Scholar 

  357. Tillett, W. S. (1): Cutaneous reactions of the polysaccharides and proteins of pneumo coccus in lobar pneumonia. J. of exper. Med. 50, 687–701 (1929).

    CAS  Google Scholar 

  358. Tillett, W. S (2): Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J. of exper. Med. 52, 561–571 (1930).

    CAS  Google Scholar 

  359. Trancu-Rainer, M.: Pneumokokken-Vulvovaginitis. Zbl. Gynäk. 1930, 1356–1357.

    Google Scholar 

  360. Trask, J. D., Ch. O’Donoran jr., D. M. Moore and A. R. Beebe: Studies on pneumonia in children I. J. clin. Invest. 8, 623–653 (1930).

    CAS  Google Scholar 

  361. Trente, E.: Tipi e virulenza dei pneumococchi nella polmonite. Polielinieo, sez. prat., 1930, 28.

    Google Scholar 

  362. Trevan, J. W.: The accuracy of titration of antipneumococcal serum. J. of Path. 33, 739–748 (1930).

    Google Scholar 

  363. Truche: Préparation et propriétés de sérum antipneumococcique. Ann. Inst. Pasteur 98 (1920).

    Google Scholar 

  364. Ungermann: Eine einfache Methode zur Gewinnung von Dauerkulturen. Arb. Reiehsgesdh.- amt 51, 180 (1919).

    Google Scholar 

  365. Unkada, S. u. J. Kako: Über die S chwankungen der Resistenz gegen Pneumokokken- infektion nach Immunisierung mit Heterobakterien. Z. Immun.forschg 67, 83–90 (1930).

    Google Scholar 

  366. Vaux, C. J.: Pneumonia from a public health, point of view with especial reference to pneumonia quarantine. J. amer. med. Assoc. 87, 1980 (1926).

    Google Scholar 

  367. Yebdina, C.: Importanza etiologica del pneumococco nelle pneumoniti da aspirazione post-emoftoiche. Riv. Pat. e Clin. Tbc. 4, 207–220 (1930).

    Google Scholar 

  368. Vogel, K.: Erfahrungen über Mueosus-Otitis. Z. Hals- usw. Heilk. 22, H. 4, 357–363.

    Google Scholar 

  369. Voithenberg, v.: Die Behandlung der akuten fibrinösen Pneumonie mit spezifischem Serum. Dtsch. Arch. klin. Med. 162, H. 5/6, 280–291 (1928).

    Google Scholar 

  370. Wadsworth, A. (1): Review of recently-published reports on the serumtreatment of type I-pneumonia. Amer. J. Hyg. 4, 119 (1924).

    Google Scholar 

  371. Wadsworth, A. (2): Die Serumtherapie der Pneumonie des Typus I. Seuehenbekämpfg 7, H. 1 (1930).

    Google Scholar 

  372. Wadsworth, A. U. Kirkbride: A note on the production of antipneumoeoceus sera; J. of exper. Med. 25, 629 (1917).

    CAS  Google Scholar 

  373. Wadsworth, A. u. Gilbert: Standardization of antipneumoeoceus and antimeningococcus serum. Arch. int. Med. 23, 269 (1919).

    Google Scholar 

  374. Wadsworth, A. Sickles: A study of pneumococci isolated from horses undergoing pneumococcus immunisation. J. of exper. Med. 45, 787 (1927).

    CAS  Google Scholar 

  375. Wahlgren, P.: On the frequency of croupy pneumonia in Stockholm before and after the influenza epidemie 1918–1919. Acta med. scand. (Stoekh.) Suppl. 16, 643–650 (1926).

    Google Scholar 

  376. Wamoscher, L. (1): Infektionsversuche mit einzelnen Pneumokokken. Z. Hyg. 106, 421 432.(1926).

    Google Scholar 

  377. Wamoscher, L. (2): Über Pneumokokkeninfektionen bei verminderter individueller Resistenz. Z. Hyg. 107, 240–252 (1927).

    Google Scholar 

  378. Ward, H. K.: Observations on the phagocytosis of the pneumococcus by human whole blood. I. The normal phagocytic titre and the anti-phagocytie effect of the specific soluble substance. II. The neutralisation of the antiphagocytic action of the specific soluble substance by antiserum. J. of exper. Med. 51, 675–684, 685–702 (1930).

    CAS  Google Scholar 

  379. Wash, Ch.: Untersuchungen über die Virulenz der Pneumokokken sowie über Schutzstoffe gegen Pneumokokken im menschlichen Serum. Inaug.-Diss. Heidelberg 1931.

    Google Scholar 

  380. Webster, L. T. u. T. P. Hughes: The epidemiology of pneumococcus infection. The incidence and spread of pneumococci in the nasal passages on throats of healthy persons. J. of exper. Med. 53, 535–552 (1931).

    CAS  Google Scholar 

  381. Welikanow, L. u. S. Michailowa: Vergärung von Kohlehydraten durch Pneumokokken als Kennzeichen ihrer Avirulenz. II. Zbl. Bakter. I Orig. 117, 219–223 (1930).

    Google Scholar 

  382. Westlund, R. E.: The incidence of pneumococcus types in pneumonies of children. J. inf. Dis. 38, 514–519 (1926).

    Google Scholar 

  383. Whittle, C. H. (1): The virulence of pneumococci in pneumonia. Brit. med. J. 1927 II, 134.

    Google Scholar 

  384. Whittle, C. H. (2): The determination of virulence of pneumococci freshly isolated from human lesions. J. of Path. 30, 568–570 (1927).

    Google Scholar 

  385. Whittle, C. H. (3): The relations of virulence in pneumococci to disease, with a comparison of virulence of the different types of pneumococci in various pathological conditions. J. of Hyg. 27, 412–423 (1928).

    CAS  Google Scholar 

  386. Whittle, C. H. (4): On the identification of pneumococci and the tests employed for distinguishing them from streptococci. J. of Hyg. 27, 200–214 (1928).

    CAS  Google Scholar 

  387. Whittle, C. H. (5): Lobar pneumonia as an infectious disease. Brit. med. J. 1928, 153.

    Google Scholar 

  388. Whittle, C. H. (6): Further observations on pneumococcal infections. Brit. med. J. 1929, 898–900.

    Google Scholar 

  389. Williams, J. W. (1): I. Relation of bile salts, Cholesterin, sodium citrate and sodium carbonate to toxicity of pneumococcus. Proc. Soc. exper. Biol. a. Med. 27, 637–639 (1930).

    Google Scholar 

  390. Williams, J. W. (2): H. Comparison of inulin bile titration and virulence of pneumococcus. Proc. Soc. exper. Biol. a. Med. 27, 639–641 (1930).

    Google Scholar 

  391. Werth, E. (1): Der Erreger der akuten Mittelohrentzündung. Beitrag zur Bakteriologie des Streptococcus mucosus. Zbl. Bakter. I Orig. 98, 501–506 (1926).

    Google Scholar 

  392. Werth, E. (2): Die Pneumokokkentypen in der Oto-Rhinologie. Zbl. Bakter. I Orig. 102, 40–4

    Google Scholar 

  393. Wisner, B.: Epidémie de pneumoeoccie, chez les singes inférieures arretée par la vaccination préventive. C. r. Soc. Biol. Paris 98, 458–459 (1928).

    Google Scholar 

  394. Wolfsohn, G.: Über Pneumokokkenperitonitis. Med. Welt 1930, Nr 49.

    Google Scholar 

  395. Woods, H. M.: Ou the statistical epidemiology of respiratory diseases. Lancet 1928 I, 539.

    Google Scholar 

  396. Wright, H. D. (1): Experimental pneumococcal septicaemia and anti-pneumococcal immunity. J. of Path. 30, 185–252 (1927).

    Google Scholar 

  397. Wright, H. D.(2): The effect of certain factors upon the growth of the pneumococcus. J. of Path. 32, 203–227 (1929).

    CAS  Google Scholar 

  398. Wynn, W. H.: The treatment of acute lobar pneumonia. II. The vaccine treatment of acute pneumonia. Brit. med. J. 1927, 480–483.

    Google Scholar 

  399. Yoshioka: Untersuchung zur Pneumokokkenimmunität. I. II. III. IY. V. Z. Hyg. 96, 520 (1922); 97, 232 (1922); 97, 386, 408; 99, 193 (1923).

    Google Scholar 

  400. Yottrevitch, V.: Culture latente pour la conversation des pneumocoques et d’autres microbes au point de vue de leur vitalité et de leur virulence. G. r. Soc. Biol. Paris 103, 320–321 (1930).

    Google Scholar 

  401. Zinsser, H.: An immunological consideration of pneumonia and a discussion of the rational basis for vaccine therapy. New England J. Med. 200, 853–857 (1929).

    Google Scholar 

  402. Zozaya, Jose, John Boyer and Janet Clark: The standardization of antipneumoeoceic serum types I and II. J. of exper. Med. 52, 471–476 (1930).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Heidelberg, Deutschland

    M. Gundel

Authors
  1. M. Gundel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Wiesbaden, Deutschland

    Wolfgang Weichardt

Additional information

Besonderer Hinweis

Dieses Kapitel ist Teil des Digitalisierungsprojekts Springer Book Archives mit Publikationen, die seit den Anfängen des Verlags von 1842 erschienen sind. Der Verlag stellt mit diesem Archiv Quellen für die historische wie auch die disziplingeschichtliche Forschung zur Verfügung, die jeweils im historischen Kontext betrachtet werden müssen. Dieses Kapitel ist aus einem Buch, das in der Zeit vor 1945 erschienen ist und wird daher in seiner zeittypischen politisch-ideologischen Ausrichtung vom Verlag nicht beworben.

Rights and permissions

Reprints and permissions

Copyright information

© 1931 Julius Springer in Berlin

About this chapter

Cite this chapter

Gundel, M. (1931). Die Bakteriologie, Epidemiologie und spezifische Therapie der Pneumokokkeninfektionen des Menschen unter besonderer Berücksichtigung der Pneumonie. In: Weichardt, W. (eds) Ergebnisse der Hygiene Bakteriologie Immunitätsforschung und Experimentellen Therapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-92399-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-92399-9_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-90542-1

  • Online ISBN: 978-3-642-92399-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation